| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 08/22/2001 | CN1309701A Starch debranching enzymes |
| 08/22/2001 | CN1309700A Glucoamylase variants |
| 08/22/2001 | CN1309699A Phytase variants |
| 08/22/2001 | CN1309184A Operation of enzymatic vitality of protoporphyrin primary oxidase in eukaryote |
| 08/21/2001 | USRE37336 Method for providing hyaluronic acid |
| 08/21/2001 | US6278041 Nucleotide sequence; for transgenic plants with insect resistance |
| 08/21/2001 | US6277980 Mixed backbone oligonucleotide analog having nucleotide sequence complementary to e6/e7 genes; has phosphorothioate bonds and at least one other phosphorus linking group or modification; viricides |
| 08/21/2001 | US6277979 KIAA0551 polynucleotides and polypeptides use |
| 08/21/2001 | US6277975 Fusions of P-selectin ligand protein and polynucleotides encoding same |
| 08/21/2001 | US6277965 Amino acid sequence of cysteinyl trna (transfer ribonucleic acid) synthetase from chlamydia; bactericides; bacteriostats; enzyme inhibitors; drug screening; diagnosis; vaccines |
| 08/21/2001 | US6277963 Antibodies directed toward extracellular signal-related kinases |
| 08/21/2001 | US6277955 Materials and method for the detection and treatment of Wegener's granulomatosis |
| 08/21/2001 | US6277827 Stability makes the novel species suitable for milling, compression and improved bioavailability; 2s-(4-(2, 5-dioxopyrrolidin-1-yl)-2s-mercaptobutyrylamino)-4-methylpenta noic acid (2,2-dimethyl-1s-methylcarbamoylpropyl)amide |
| 08/21/2001 | US6277818 Cyclic peptide ligands that target urokinase plasminogen activator receptor |
| 08/21/2001 | US6277806 Enzyme fused to a heavy chain immunoglobulin raised in camelidae and has a specificity for non-colored compounds present in stains and fabrics, surfactant and transition metal catalyst |
| 08/21/2001 | US6277638 Producing nucleic acid fragments or polynucleotides conferring desired phenotype which encodes mutant proteins via repeated cycles of in vitro or in vivo recombination (mutagenesis, shuffling, and selection) |
| 08/21/2001 | US6277634 Hybridized with target rna to be cleaved; medical diagnosis or gene therapy, drugs |
| 08/21/2001 | US6277623 Vector for use as tool in genetic engineering |
| 08/21/2001 | US6277622 Synthetic polynucleotides |
| 08/21/2001 | US6277620 Polypeptide for the prevention of bacterial infection; bactericides; for vaccine development |
| 08/21/2001 | US6277619 Enzymatic polypeptide associated with generating glucose; for the diagnosis, treatment, and prevention of disorders of metabolism and cancer |
| 08/21/2001 | US6277618 Enzymatic protein; for use in diagnosis of blood disorders; for use in detection of modulators of blood coagulation |
| 08/21/2001 | US6277617 Chemically modified enzymes |
| 08/21/2001 | US6277616 Endo-fucoidan-lyase |
| 08/21/2001 | US6277615 (1→3, 1→4)—β-glucanase of enhanced stability |
| 08/21/2001 | US6277614 Enzymatic protein associated with recombination; for use as tool in genetic engineering and gene therapy |
| 08/21/2001 | US6277613 TRF1 binding protein, methods of use thereof |
| 08/21/2001 | US6277612 Polypeptides having galactose oxidase activity and nucleic acids encoding same |
| 08/21/2001 | US6277611 Variant enzymatic polypeptide; for use in lignin adjustment, paper strenthening, dye transfer suppression in detergent, bleaching of textiles and waste water treatment; bioremediation |
| 08/21/2001 | US6277608 Cloning target nucleotide sequences; mixing expression vector and target nucleotide sequences, incubate with recombinase, amplify and recover target sequences |
| 08/21/2001 | US6277599 Monoclonal antiboby for the preferential killing of tumors; for diagnosis of cancer; for the treatment of cancer |
| 08/21/2001 | US6277597 Nucleotide sequences coding microbiocides; for the prevention of bacterial infection |
| 08/21/2001 | US6277596 Regulatory sequence of cellulase cbh1 genes originating in trichoderma viride and system for mass-producing proteins or peptides therewith |
| 08/21/2001 | US6277590 Genetically engineered aggregates for generating preferential heterologous proteins |
| 08/21/2001 | US6277586 Used for detecting the presence of autoantibodies to glutamic acid decarboxylaes (gad) in a biological sample |
| 08/21/2001 | US6277574 Genes associated with diseases of the kidney |
| 08/21/2001 | US6277572 Human NADH dehydrogenase subunits |
| 08/21/2001 | US6277568 Nucleic acids encoding human ubiquitin-conjugating enzyme homologs |
| 08/21/2001 | US6277564 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 08/21/2001 | US6277399 Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections |
| 08/21/2001 | US6277377 Using the polypeptide to screen a plurality of molecules to identify at least one molecule which specifically binds the polypeptide |
| 08/21/2001 | US6277373 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase |
| 08/21/2001 | CA2334041A1 Enzyme with xylanase activity |
| 08/21/2001 | CA2093793C Alkylidene analogs of 1'-aminospiro¬isoquinoline-4(1h),-3'-pyrrolidine|1,2',3,5'(2h)-tetrones useful as aldose reductase inhibitors |
| 08/18/2001 | CA2332533A1 Novel metalloproteases having thrombospondin domains and nucleic acid compositions encoding the same |
| 08/16/2001 | WO2001059158A1 Compositions and methods for the early diagnosis of ovarian cancer |
| 08/16/2001 | WO2001059152A2 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 08/16/2001 | WO2001059140A1 Transgenic cells expressing glucosyltransferase nucleic acids |
| 08/16/2001 | WO2001059139A2 Ozone and/or pathogen-inducible gene expression in plants |
| 08/16/2001 | WO2001059137A1 Method for remodelling cell wall polysaccharide structures in plants |
| 08/16/2001 | WO2001059136A1 Production of non-cariogenic sugars in transgenic plants |
| 08/16/2001 | WO2001059135A1 Method for influencing the pollen development by modifying the sucrose metabolism |
| 08/16/2001 | WO2001059134A1 Human proteases and polynucleotides encoding the same |
| 08/16/2001 | WO2001059133A1 Larynx carcinoma-associated protein larcap-1 |
| 08/16/2001 | WO2001059132A1 Novel human lysozymes and polynucleotides encoding the same |
| 08/16/2001 | WO2001059131A2 Use of palatinase and trehalulase sequences as nutritive markers in transformed cells |
| 08/16/2001 | WO2001059130A2 Proteins producing an altered immunogenic response and methods of making and using the same |
| 08/16/2001 | WO2001059129A2 Mammalian secreted group iii phospholipase a2 |
| 08/16/2001 | WO2001059128A2 Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 08/16/2001 | WO2001059127A2 Drug metabolizing enzymes |
| 08/16/2001 | WO2001059126A2 Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility |
| 08/16/2001 | WO2001059112A1 Anti-angiogenic intestinal peptides, zdint5 |
| 08/16/2001 | WO2001059103A2 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression |
| 08/16/2001 | WO2001059102A2 Nucleozymes with endonuclease activity |
| 08/16/2001 | WO2001059090A2 CDK4 IS A TARGET OF c-MYC |
| 08/16/2001 | WO2001059085A1 Protecting molecules in biologically derived compositions while treating with broad-spectrum pulsed light |
| 08/16/2001 | WO2001059084A1 Protein c derivatives |
| 08/16/2001 | WO2001059083A1 Bacterial galactanases and use thereof |
| 08/16/2001 | WO2001059082A1 27802, an adenylate kinase |
| 08/16/2001 | WO2001059081A2 Methods for using 20893, a human protein kinase |
| 08/16/2001 | WO2001059080A1 18477, a human protein kinase and uses therefor |
| 08/16/2001 | WO2001059079A1 UDP-GALACTOSE: β-D-GALACTOSE-R 4-α-D-GALACTOSYLTRANSFERASE, α4GAL-T1 |
| 08/16/2001 | WO2001059078A2 Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
| 08/16/2001 | WO2001059075A1 Improved sialylation of glycoproteins |
| 08/16/2001 | WO2001059064A2 Nucleic acids, proteins, and antibodies |
| 08/16/2001 | WO2001058936A2 Constructs for delivery of therapeutic agents to neuronal cells |
| 08/16/2001 | WO2001058935A2 FACTOR VII OR VIIa-LIKE MOLECULES |
| 08/16/2001 | WO2001058924A2 Novel resin materials and their use for recovering proteins or peptides |
| 08/16/2001 | WO2001058921A2 Methods and compositions for generating angiostatin |
| 08/16/2001 | WO2001058482A1 Anti-human mitochondrial adenylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease |
| 08/16/2001 | WO2001058472A2 Botulinum toxin pharmaceutical compositions |
| 08/16/2001 | WO2001058276A2 Use of acid-stable proteases in animal feed |
| 08/16/2001 | WO2001058275A2 Use of acid-stable subtilisin proteases in animal feed |
| 08/16/2001 | WO2001011024A3 Bryostatins, bryopyrans and polyketides: compositions and methods |
| 08/16/2001 | WO2001009347A3 Archaeal replication accessory factors and methods of use |
| 08/16/2001 | WO2001009293A3 Mammalian adhesion protease peptides |
| 08/16/2001 | WO2001009292A3 Sentrin-specific human proteases senp1-3 |
| 08/16/2001 | WO2001007628A3 Human synthetases |
| 08/16/2001 | WO2001007579A3 Methods and compositions for determining enzymatic activity |
| 08/16/2001 | WO2000078983A3 Sunflower anti-pathogenic proteins and genes and their uses |
| 08/16/2001 | WO2000058352A3 Barley gene for thioredoxin and nadp-thioredoxin reductase |
| 08/16/2001 | WO2000055307A3 A method for increasing the processivity of a dna- or rna-dependent polymerase and compositions therefor |
| 08/16/2001 | WO2000023603A9 Methods of treatment of type 2 diabetes |
| 08/16/2001 | US20010014977 DNA sequence encoding protein for pigment synthesis; modifying color phenotype of plant tissue |
| 08/16/2001 | US20010014659 Laundry and cleaning compositions containing xyloglucanase enzymes |
| 08/16/2001 | US20010014467 Reacting trans-ferulic acid and coenzyme a (CoASH) under trans-ferulate:CoASH ligase enzyme activity, trans-feruloyl SCoA hydratase activity, and 4-hydroxy-3-methoxyphenyl-beta-hydroxypropionyl SCoA cleavage activity; Pseudomonas enzymes |
| 08/16/2001 | US20010014463 Lysozyme-like enzymes capable of killing cariogenic bacteria; also methods for studying the cell wall of oral bacterium, preventing spoilage of perishable items and removing dextrans from surfaces used in sugar refining |
| 08/16/2001 | US20010014444 Gene regulator fusion proteins and methods of using the same for determining resistance of a protein to a drug targeted thereagainst |
| 08/16/2001 | US20010014356 Silica coated zinc oxide adsorber for rough skin sensitivity |
| 08/16/2001 | US20010014334 Methods and materials for the treatment of prostatic carcinoma |